SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-015039
Filing Date
2021-11-08
Accepted
2021-11-08 16:16:11
Documents
62
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q tgtx-20210930x10q.htm   iXBRL 10-Q 1868998
2 EX-31.1 tgtx-20210930xex31d1.htm EX-31.1 13509
3 EX-31.2 tgtx-20210930xex31d2.htm EX-31.2 13487
4 EX-32.1 tgtx-20210930xex32d1.htm EX-32.1 6637
5 EX-32.2 tgtx-20210930xex32d2.htm EX-32.2 6597
  Complete submission text file 0001558370-21-015039.txt   6149854

Data Files

Seq Description Document Type Size
6 EX-101.SCH tgtx-20210930.xsd EX-101.SCH 44701
7 EX-101.CAL tgtx-20210930_cal.xml EX-101.CAL 52807
8 EX-101.DEF tgtx-20210930_def.xml EX-101.DEF 143969
9 EX-101.LAB tgtx-20210930_lab.xml EX-101.LAB 351519
10 EX-101.PRE tgtx-20210930_pre.xml EX-101.PRE 255858
11 EXTRACTED XBRL INSTANCE DOCUMENT tgtx-20210930x10q_htm.xml XML 923728
Mailing Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32639 | Film No.: 211388161
SIC: 2834 Pharmaceutical Preparations